Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
äŒæ¥ã³ãŒãAIFF
äŒç€ŸåFirefly Neuroscience Inc
äžå Žæ¥Oct 27, 1993
æé«çµå¶è²¬ä»»è
ãCEOãLipschitz (Greg)
åŸæ¥å¡æ°13
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Oct 27
æ¬ç€Ÿæåšå°1100 Military Road
éœåžKENMORE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·14217
é»è©±çªå·18882376412
ãŠã§ããµã€ãhttps://fireflyneuro.com/
äŒæ¥ã³ãŒãAIFF
äžå Žæ¥Oct 27, 1993
æé«çµå¶è²¬ä»»è
ãCEOãLipschitz (Greg)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã